Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the BREVACTA study of RoACTEMRA (tocilizumab, known as ACTEMRA outside Europe) given as a subcutaneous (SC) injection to patients with ...
For the first time, a study has demonstrated that deoxycholic acid, the main ingredient in Daewoong Pharmaceutical's fat-dissolving injection 'Violette', is effective in breaking down subcutaneous fat ...
Subcutaneous nivolumab and hyaluronidase-nvhy is FDA-approved for adult solid tumors, offering a new administration route for PD-1 inhibitors. The phase 3 CheckMate-67T trial confirmed noninferiority ...
While administering monoclonal antibodies via intravenous infusion is standard practice to prevent severe hospitalization and death in outpatients with COVID-19, new research from UPMC shows giving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback